MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

Michael Ljungberg; Anna Celler; Mark W Konijnenberg; Keith F Eckerman; Yuni K Dewaraja; Katarina Sjögreen Gleisner

doi:10.2967/jnumed.115.159012

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

Michael Ljungberg, Anna Celler, Mark W Konijnenberg, Keith F Eckerman, Yuni K Dewaraja, Katarina Sjögreen Gleisner

Medical Radiation Physics, Lund

Research output: Contribution to journal › Article › peer-review

Abstract

Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.

Original language	English
Pages (from-to)	151-162
Journal	Journal of Nuclear Medicine
Volume	57
Issue number	1
DOIs	https://doi.org/10.2967/jnumed.115.159012
Publication status	Published - 2016

Subject classification (UKÄ)

Radiology, Nuclear Medicine and Medical Imaging
Other Physics Topics

Access to Document

10.2967/jnumed.115.159012

http://www.ncbi.nlm.nih.gov/pubmed/26471692?dopt=Abstract

Cite this

@article{b7bfa6224d04454b8e66908a6a4b33c4,

title = "MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.",

abstract = "Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.",

author = "Michael Ljungberg and Anna Celler and Konijnenberg, {Mark W} and Eckerman, {Keith F} and Dewaraja, {Yuni K} and {Sj{\"o}green Gleisner}, Katarina",

year = "2016",

doi = "10.2967/jnumed.115.159012",

language = "English",

volume = "57",

pages = "151--162",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine",

number = "1",

}

TY - JOUR

T1 - MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

AU - Ljungberg, Michael

AU - Celler, Anna

AU - Konijnenberg, Mark W

AU - Eckerman, Keith F

AU - Dewaraja, Yuni K

AU - Sjögreen Gleisner, Katarina

PY - 2016

Y1 - 2016

N2 - Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.

AB - Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.

U2 - 10.2967/jnumed.115.159012

DO - 10.2967/jnumed.115.159012

M3 - Article

C2 - 26471692

VL - 57

SP - 151

EP - 162

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this